University of Oxford
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers
Not Applicable
Completed
- Conditions
- Typhoid Vaccine on Sleep
- Interventions
- Biological: PlaceboBiological: Typhoid Vaccine
- First Posted Date
- 2015-12-11
- Last Posted Date
- 2018-05-14
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 16
- Registration Number
- NCT02628054
Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative
Completed
- Conditions
- BiosensorsGenotypingValidation
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2018-02-19
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 150
- Registration Number
- NCT02625285
- Locations
- 🇹🇭
Shoklo Malaria Research Unit,, Mae Sot, Tak, Thailand
Using Thoracic Ultrasound to Predict Pleurodesis Success in Malignant Pleural Effusions: a Pilot Study
Completed
- Conditions
- Malignant Pleural Effusion
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 18
- Registration Number
- NCT02625675
- Locations
- 🇬🇧
Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, United Kingdom
Advanced Ultrasound in Pleural Infection
Not Applicable
Completed
- Conditions
- Pleural Infection
- First Posted Date
- 2015-11-20
- Last Posted Date
- 2017-05-16
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 20
- Registration Number
- NCT02608814
- Locations
- 🇬🇧
North Bristol NHS Trust, Southmead Hospital, Bristol, United Kingdom
🇬🇧Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, United Kingdom
ActiPatch Therapy for Back Pain
Not Applicable
- Conditions
- Back Ache
- Interventions
- Device: ActiPatch (active)Device: ActiPatch (placebo)
- First Posted Date
- 2015-11-10
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 30
- Registration Number
- NCT02601807
- Locations
- 🇬🇧
John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom
A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- Biological: R21 with ASO1B
- First Posted Date
- 2015-11-09
- Last Posted Date
- 2017-06-20
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 20
- Registration Number
- NCT02600975
- Locations
- 🇬🇧
CCVTM, University of Oxford, Oxford, United Kingdom
🇬🇧NIHR Wellcome Trust Clinical Research Facility, Southampton, United Kingdom
Individualised Informal Caregiver Training for Palliative Care at Home
Not Applicable
Terminated
- Conditions
- Palliative Care
- Interventions
- Behavioral: Caregiver training
- First Posted Date
- 2015-10-29
- Last Posted Date
- 2016-06-03
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 14
- Registration Number
- NCT02591693
- Locations
- 🇬🇧
Sir Michael Sobell House Hospice, Oxford, Oxfordshire, United Kingdom
Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation
Not Applicable
Completed
- Conditions
- Parkinson Disease
- Interventions
- Procedure: Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015)Procedure: Deep Brain Stimulation offProcedure: closed-loop Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015)Device: local field potentials and electroencephalography recordings
- First Posted Date
- 2015-10-23
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 30
- Registration Number
- NCT02585154
- Locations
- 🇬🇧
University College London Hospitals NHS Trust, London, United Kingdom
🇬🇧Oxford University Hospitals NHS Trust, Oxford, United Kingdom
Aetiology of TemporaL Arteritis Study
Withdrawn
- Conditions
- Temporal Arteritis
- First Posted Date
- 2015-10-22
- Last Posted Date
- 2022-08-15
- Lead Sponsor
- University of Oxford
- Registration Number
- NCT02584517
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- Biological: R21Biological: Matrix-M1
- First Posted Date
- 2015-10-08
- Last Posted Date
- 2019-11-12
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 31
- Registration Number
- NCT02572388
- Locations
- 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
🇬🇧NIHR Wellcome Trust Clinical Research Facility, Hammersmith Hospital, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath